Rethinking How Injectable Medicine Is Stored and Delivered.
Built to replace the syringe, not improve it.
Conventional Syringe
MIST System
Actuation
Plunger, manual push, direct contact.
Plunger-less, magnetically actuated
.
Sterility
Silicone oil lubricant — contamination and protein aggregation risk.
Zero silicone oil, zero contact — no leachables.
Dosing Accuracy
Air bubbles require overfill to compensate
Zero air bubbles, zero overfill
Cold Chain
Required for most biologics
Reduced or eliminated — vacuum/inert-gas sealed
Formulation Range
Liquids only; struggles with viscous or gas-based drugs
Liquids, viscous formulations, semi-solids, and gases
Cost Impact
Baseline
30–60% lower cold-chain cost, 10–18% lower drug waste
“
Real progress in healthcare starts with reducing the burden on patients. MIST does that — less waste, less friction, more dignity in self-care.
Our Team of Experts
Founded in 2026, Avicenna Therapeutic Tech, Inc., a DE C-corp. set out to solve a problem the industry had accepted: how to keep injectable medication stable and sterile without compromise.
Our team draws on decades of experience across medical devices, pharma, biotech, and manufacturing to bring MIST from concept to reality.
Learn More
Ready to Rethink Drug Delivery?
Whether you're a pharma partner, investor, or just curious about the technology, we'd love to talk.
